Amylyx Pharmaceuticals Inc (AMLX) — Capital Reinvestment Ratio
Amylyx Pharmaceuticals Inc (AMLX) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($13.55 Million) in capital expenditures ($356.00K). Check how tangible is Amylyx Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amylyx Pharmaceuticals Inc Capital Reinvestment Ratio (2023–2023)
This chart tracks Amylyx Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Amylyx Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year Capital Reinvestment Ratio for Amylyx Pharmaceuticals Inc from 2023 to 2023. See Amylyx Pharmaceuticals Inc (AMLX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | $11.92 Million | $1.24 Million | — |